C12Y 305/01004
Amidase
Official title: Amidase (3.5.1.4)
C12Y305/01004 (Amidase) appears on 18 US grants and 37 published applications in this corpus.
Search patents in C12Y- Granted patents
- 18
- Published applications
- 37
- Assignees
- 29
- Inventors
- 73
- Latest grant
- 27 Jan 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1997 | 1 | 0 |
| 1998 | 0 | 0 |
| 1999 | 0 | 0 |
| 2000 | 0 | 0 |
| 2001 | 0 | 0 |
| 2002 | 0 | 0 |
| 2003 | 0 | 0 |
| 2004 | 0 | 0 |
| 2005 | 0 | 0 |
| 2006 | 0 | 0 |
| 2007 | 0 | 1 |
| 2008 | 1 | 1 |
| 2009 | 1 | 2 |
| 2010 | 2 | 3 |
| 2011 | 0 | 0 |
| 2012 | 1 | 2 |
| 2013 | 0 | 1 |
| 2014 | 1 | 0 |
| 2015 | 2 | 3 |
| 2016 | 0 | 0 |
| 2017 | 0 | 1 |
| 2018 | 0 | 0 |
| 2019 | 0 | 0 |
| 2020 | 1 | 0 |
| 2021 | 0 | 3 |
| 2022 | 1 | 2 |
| 2023 | 0 | 4 |
| 2024 | 1 | 7 |
| 2025 | 5 | 5 |
| 2026 | 1 | 2 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Borrelia burgdorferi peptidoglycan as a diagnostic and target for therapeutic intervention of Lyme disease-related pathologies27 Jan 2026US 12,535,481 B2Virginia Tech Intellectual Properties, Inc.
- DNA modifying enzymes and active fragments and variants thereof and methods of use26 Aug 2025US 12,398,384 B2Life Edit Therapeutics, Inc.
- DNA modifying enzymes and active fragments and variants thereof and methods of use18 Mar 2025US 12,252,718 B2Life Edit Therapeutics, Inc.
- Gene therapy of the FAAH pseudogene4 Mar 2025US 12,241,066 B2UCL Business PLC
- Nucleic acid molecules encoding DNA modifying enzymes and active fragments and variants thereof and compositions comprising the same7 Jan 2025US 12,188,061 B2Life Edit Therapeutics, Inc.
- Borrelia burgdorferi peptidoglycan as a diagnostic and target for therapeutic intervention of lyme disease-related pathologies4 Jun 2026US 2026/0153509 A1Virginia Tech Intellectual Properties, Inc.
- Enzymes for the biological catabolism of acetamide from oxidized nylon waste5 Mar 2026US 2026/0062721 A1Alliance for Sustainable Energy, LLC
- Dna modifying enzymes and active fragments and variants thereof and methods of use7 Aug 2025US 2025/0250554 A1Life Edit Therapeutics, Inc.
- Clyrd, a novel chimeric endolysin from clostridium perfringens phages with enhanced antibacterial activity8 May 2025US 2025/0145980 A1Foundation for Research and Business, Seoul National University of Science and Technology
- Method for the removal of acrylamide from foods and stimulants1 May 2025US 2025/0134125 A1ANKA Angewandte Kaffeetechnologie GmbH
Most cited
By later US patents
- Medical use, a medical method and a pharmaceutical preparation36US 5,607,671 A1997
- Nucleic acids and proteins and methods for making and using them18US 8,119,385 B2BP Corporation North America Inc. · 2012
- Food additive comprising an amidase for detoxifying ochratoxin5US 9,113,649 B2Dupont Nutrition Biosciences Aps · 2015
- Nucleic acids and proteins and methods for making and using them2US 8,962,800 B2BP Corporation North America Inc. · 2015
- Method for producing an amide1US 10,655,152 B2Solenis Technologies, L.P. · 2020